Phase I, dose escalation, pharmacokinetics (PK) and pharmacodynamic (PD) study of ZD 1839: NCIC CTG IND.122. Proceedings of the 11th NCI-EORTC-AACR Symposium [abstract 382] - Goss,G. (Clin Cancer Res, 2000)